Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
American Diabetes Association (ADA 2003) Standards of medical care for patients with diabetes mellitus. Diabetes Care 26(Suppl. 1): 33–50
Amin R, Ross K, Acerini CL, Edge JA, Warner J, Dunger DB (2003) Hypoglycemia prevalence in prepubertal children with type 1 diabetes on standard insulin regimen: use of continuous glucose monitoring system. Diabetes Care 26: 662–667
Anderson BJ, Wolf FM, Burkhart MT, Cornell RG, Bacon GE (1989) Effects of peer-group intervention on metabolic control of adolescents with IDDM. Diabetes Care 12: 179–183
Arbeitsgemeinschaft für Pädiatrische Diabetologie (AGPD 2004) Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes-und Jugendalter. In: Scherbaum WA (Hrsg) Evidenzbasierte Diabetes-Leitlinien DDG. Deutsche Diabetes Gesellschaft, Bochum
Bougnères PF, Landais P, Mairesse AM et al. (1993) Improvement of diabetic control and acceptability of a three-injection insulin regimen in diabetic adolescents. Diabetes Care 16: 94–102
Burger W, Weber B, Ender I, Hartmann R (1991) Therapie des Diabetes mellitus im Kindes-und Jugendalter. Monatsschr Kinderheilkd 139: 62–68
Caplin NJ, O’Leary P, Bulsara M, Davis EA, Jones TW (2003) Subcutaneous glucose sensor values closely parallel blood glucose during insulin-induced hypoglycaemia. Diabetic Med 20: 238–241
Chase HP, Jackson WE, Hoops SL, Cockerham RS, Archer PG, O’Brien D (1989) Glucose control and the renal and retinal complications of insulin-dependent diabetes. JAMA 261: 1155–1160
Chase HP, Kim LM, Owen SL, MacKenzie TA, Klingensmith GJ, Murtfeld R, Garg SK (2001) Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics 2: 222–226
Chase HP, Roberts MD, Wightman C et al. (2003) Use of the GlucoWatch biographer in children with type 1 diabetes. Pediatrics 111 (4 Pt 1): 790–794
Christensen NK, Terry RD, Wyatt S, Pichert JW, Lorenz RA (1983) Quantitative assessment of dietary adherence in patients with insulin-dependent diabetes mellitus. Diabetes Care 6: 245–250
Clegg MD, Schroeder WA (1959) A chromatographie study of the minor components of normal adult human hemoglobin including a comparison of hemoglobin from normal and phenylketonuric individuals. J Am Chem Soc 81: 6065
Dahl-Jørgensen K, Brinchmann-Hansen O, Bangstedt HJ, Hanssen K (1994) Blood glucose control and microvascular complications — what do we do now? Diabetologia 37: 1172–1177
Dahl-Jørgensen K, Brinchmann-Hansen O, Hanssen K, Ganes T, Kierulf P, Smeland E (1986) effect of near normoglycaemia for two years on progression of early diabetic retinopthy, nephropathy and neuropathy: the Oslo study. BMJ 293: 1195–1199
Daneman D, Wolfson DH, Becker DJ, Drash AL (1981) Factors affecting glycosylated hemoglobin values in children with insulin dependent diabetes. J Pediatr 99: 847–853
Danne T, Deiss D, Hopfenmüller W, von Schütz W, Kordonouri O (2002) Experience with insulin analogues in children. Horm Res 57(Suppl. 1): 46–53
Danne T, Lüpke K, Glinda S, von Walter E, von Schütz W, Thölke B (2004) Ist eine Blutzuckertestung aus Unterarm und Daumenballen bei Kindern und Jugendlichen mit Typ-1-Diabetes verlässlich? Monatschr Kinderheilkd, im Druck
Danne T, Mortensen HB, Hougard P et al. (2001) Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study Group. Diabetes Care 24: 1342–1347
D’Antonio JA, Ellis D, Doft BH, Becker D, Drash AL, Kuller LH, Orchard TJ (1989) Diabetes complications and glycemic control. Diabetes Care 12: 694–700
DCCT Research Group (1987) Diabetes Control and Complications Trial: results of feasibility study. Diabetes Care 10: 1–19
DCCT Research Group (1987) Feasibility of centralized measurements of glycosylated hemoglobin in the Diabetes Control and Complications Trial: A multicenter study. Clin Chem 33: 2267–2271
DCCT Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–986
DCCT Research Group (1994) Effect of intensive diabetes treatment on the development and progression of longterm complications in adolescents with insulin-dependent diabetes mellitus. Diabetes Control and Complications Trial. J Pediatr 125: 177–188
DCCT Research Group (1995) The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 44: 968–983
Deiss D, Kordonouri O, Meyer K, Danne T (2001) Long hypoglycaemic periods detected by subcutaneous continuous glucose monitoring in toddlers and pre-school children with diabetes mellitus. Diabet Med 18: 337
Dollhofer R, Wieland OH (1979) Glycosylation of serum albumin in diabetic patients. FEBS Lett 103: 282
European IDDM Policy Group (1993) Consensus guidelines for the management of insulin-dependent (type I) diabetes. Medicom Europe BV, Bussum, Netherlands
Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T (1991) Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia 34: 164–170
Fiedler H (2002) Richtlinien und Empfehlungen für die Laboranalyse zur Diagnose und Behandlung des Diabetes mellitus. Diabetes Stoffwechsel 11: 287–290
Furrer J, Gautschi K, Jutz G, Rietz P (1985) Fructosamin — ein neuer Routineparameter in der Diabetes-Kontrolle. Swiss Med 7/11: 69
Goldenstein DE, Walker B, Rawlings SS, Hess RL, England JD, Peth SB, Hewett JE (1980) Hemoglobin A1c levels in children and adolescents with diabetes mellitus. Diabetes Care 3: 503–507
Gonen B, Rubenstein AH (1978) Hemoglobin A1c and diabetes mellitus. Diabetologia 15: 1–8
Hanas R (1998) Insulin-dependent diabetes in children, adolescents and adults. Piara HB Uddevalla Sweden
Hanas R (2002) Psychological impact of changing the scale of reported HbA1c results affects metabolic control. Diabetes Care 25: 2110–2111
Heinemann L, Koschinsky T (2002) Continuous glucose monitoring: an overview of today’s technologies and their clinical applications. Int J Clin Pract (Suppl. 129): 75–79
Heinze E, Vetter U, Thon A, Kohne E (1983) Der SD-Score für die Minorkomponenten des HbA1. Dtsch Med Wochenschr 108: 1632–1634
Henny J, Schiele F (1990) Altersabhängigkeit, Geschlechtsabhängigkeit und Referenzwerte von Serum-Fructosamin bei Bestimmung mit einer neuen kolorimetrischen Methode. Wien Klin Wochenschr 102: 48
Henrichs HR (1984) Indikationen und therapeutische Konsequenz der HbA1-Bestimmung. Lab Med 8: 271
Henrichs HR (1990) Diagnostik der diabetischen metabolischen Situation mit Hilfe der Fructosamin-(und HbA1c-) bestimmung. Der Glykierungsquotient Glyc-Qu, das Glykierungsnomogramm. Wien Klin Wochenschr 102–164
Henrichs HR, Bonini P, Fielding L et al. (1989) Fructosamin als Routineparameter in der Diabetes-Kontrolle. Multizentrische, klinische Erprobung eines verbesserten Fructosamintests. Akt Endokr Stoffw 10: 96
Hoelzel W, Miedema K (1996) Development of a reference system for the international standardization of HbA1c/Glycohemoglobin determinations. J Internat Fed Clin Chem 9: 62–67
Hoey H, Aanstoot HJ, Chiarelli F et al. (2001) Good metabolic control is associated with better quality of life in 2.101 adolescents with type 1 diabetes. Diabetes Care 24: 1923–1928
Holl RW, Lang G, Grabert M, Teller W, Heinze E (1995) Spätkomplikationen bei Diabetes mellitus — Beginnt die Prävention schon in der Kindheit? Monatsschr Kinderheilkd 143(Suppl. 1): 12–25
Huismann TH, Dozy AM (1962) Studies of the heterogeneity of haemoglobin. V. Binding of haemoglobin with oxidized glutathione. J Lab Clin Med 60: 302–307
Hürter P, Lange K (2001) Kinder und Jugendliche mit Diabetes. Medizinischer und psychologischer Ratgeber für Eltern. Springer, Berlin Heidelberg New York Tokio
Hürter P, von Schütz W, Lange K (1995) Methoden der Insulinsubstitution bei Kindern und Jugendlichen mit Typ-1-Diabetes. Monatsschr Kinderheilkd 143(Suppl. 1): 39–53
International Federation of Clinical Chemistry (IFCC) and Labarotory Medicine (2002) Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med 40: 78–89
International Society for Pediatric and Adolescent Diabetes (ISPAD), International Diabetes Federation World Health Organisation (2000) Consensus guidelines for the management of insulin-dependent (type I) diabetes mellitus (IDDM) in childhood and adolescence. PGF Swift. Publ. Medforum (ed), Zeist, Niederlande. http://www.ispad.org, deutsche Fassung: http://www.disetronic.de/download/0701_B_ISPAD.pdf
Jeppsson JO, Kobold U, Barr J et al. (2002) Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med 40: 78–89
Johnson RN, Metcalf PA, Baker JR (1983) Fructosamin: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin Chim Acta 127: 87
Joner G, Brinchmann-Hansen O, Torres CG, Hanssen KF (1992) A nationwide cross-sectional study of retinopathy and microalbuminuria in young Norwegian type 1 (insulin-dependent) diabetic patients. Diabetologia 35: 1049–1054
Käär ML, Åkerblom HK, Hultunen NP, Knip M, Säkkinen K (1984) Metabolic control in children and adolescents with insulin-dependent diabetes mellitus. Acta Paediatr Scand 73: 102–108
Kirschenbaum DM (1984) Glycosylation of proteins; its implications in diabetic control and complications. Pediatric Clin Nort Am 31: 611
Koenig RJ, Peterson CM, Jones RL, Sander C, Lehrmann M, Cerami A (1976) The correlations of glucose regulation and hemoglobin A1c in diabetes mellitus. N Engl J Med 295: 417–420
Kruse-Jarres JD, Jarausch J, Lehmann P, Vogt LW, Rietz P (1989) A new colorimetric method for the determination of fructosamine. Lab Med 13: 245
Little RR, Rohlfing CL, Wiedmeyer HM, Myers GL, Sacks DB, Goldstein DE (2001) The national glycohemoglobin standardization program: a fife-year progress report. Clin Chem 47: 1985–1992
Ludvigsson J, Hanas R (2003) Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics 111 (5 Pt 1): 933–938
Mastrototaro J (1999) The MiniMed Glucose Monitoring System (CGMS). J Pediatr Endocrinol Metab 12(Suppl. 3): 751–757
Molnar GD, Taylor WF, Ho MM (1972) Day-to-day variation of continuously monitored glycaemia: a further measure of diabetic instability. Diabetologia 8: 342–348
Mortensen HB, Robertson KJ, Aanstoot HJ et al. for the Hvidøre Study Group on Childhood Diabetes (1998) Diabetic Medicine 15: 752–759
Oyibo SO, Prasad YD, Jackson NJ, Jude EB, Boulton AJ (2002) The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med 19: 870–873
Poscia A, Mascini M, Moscone D et al. (2003) A microdialysis technique for continuous subcutaneous glucose monitoring in diabetic patients (part 1). Biosens Bioelectron 18: 891–898
Reichard P, Nilsson BY, Rosenquist U (1993) The effect of longterm intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329: 304–309
Renard E (2002) Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy. Curr Opin Pharmacol 2: 708–716
Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrot M (2002) Guidelines and recommendations for labaratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 25: 750–786
Salardi S, Zucchini S, Santoni R, Ragni L, Gualandi S, Cicognani A, Cacciari E (2002) The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(lc) in pediatric type 1 diabetic patients. Diabetes Care 25: 1840–1844
Santiago (1993) Lessons from the Diabetes Control and Complications Trial. Diabetes 42: 1549–1554
Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF (1970) Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 19: 644–655
Siedel J, Vogt B, Kerscher L, Ziegenhorn J (1988) Serum fructosamine assay: two different colour reagents compared with reference to a HPLC-procedure. Clin Chem 34: 1316
Snieder H, Sawtell PA, Ross L, Walker J, Spector TD, Leslie RD (2001) HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. Diabetes 50: 2858–2863
Stahl M, Jorgensen LGM, Hyltoft-Petersen P, Brandslund I, DeFine-Olivarius N, Borch-Johnsen K (2001) Optimization of oreanalytic conditions and analysis of plasma glucose. 1. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus. Scand J Lab Invest 61: 169–180
Tattersall RB, Lowe J (1981) Diabetes in adolescence. Diabetologia 20: 517–523
Trivelli LA, Ramsey HM, Lai HT (1971) Hemoglobin components in patients with diabetes mellitus. N Engl J Med 284: 353–357
UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucoe control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837–853
Vanelli M, Chiari G, Capuano C (2003) Cost effectiveness of the direct measurement of 3-beta-hydroxybutyrate in the management of diabetic ketoacidosis in children. Diabetes Care 26: 959
Willms B, Lehmann P (1990) Neuer Fructosamin-Test als Routineparameter in der Diabetes-Kontrolle. Wien Klin Wochenschr 102: 5
Wing RR, Lamparski DM, Zaslow S, Betschart J, Siminerio L, Becker D (1985) Frequency and accuracy of self-monitoring of blood glucose in children: Relationship to glycemic control. Diabetes Care 8: 214–218
Wolf J, Wolf E, Hürter P (1987) Konventionelle und intensivierte konventionelle Insulintherapie (ICT) bei Kindern und Jugendlichen mit Typ-1-Diabetes. Monatsschr Kinderheilkd 135: 770–774
Rights and permissions
Copyright information
© 2005 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
(2005). Methoden der Stoffwechselkontrolle. In: Diabetes bei Kindern und Jugendlichen. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-26602-X_10
Download citation
DOI: https://doi.org/10.1007/3-540-26602-X_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-21186-0
Online ISBN: 978-3-540-26602-0
eBook Packages: Medicine (German Language)